55 related articles for article (PubMed ID: 38450191)
1. A proteogenomic profile of early lung adenocarcinomas by protein co-expression network and genomic alteration analysis.
Nishimura T; Nakamura H; Tan KT; Zhuo DW; Fujii K; Koizumi H; Naruki S; Takagi M; Furuya N; Kato Y; Chen SJ; Kato H; Saji H
Sci Rep; 2020 Aug; 10(1):13604. PubMed ID: 32788598
[TBL] [Abstract][Full Text] [Related]
2. International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma.
Travis WD; Brambilla E; Noguchi M; Nicholson AG; Geisinger KR; Yatabe Y; Beer DG; Powell CA; Riely GJ; Van Schil PE; Garg K; Austin JH; Asamura H; Rusch VW; Hirsch FR; Scagliotti G; Mitsudomi T; Huber RM; Ishikawa Y; Jett J; Sanchez-Cespedes M; Sculier JP; Takahashi T; Tsuboi M; Vansteenkiste J; Wistuba I; Yang PC; Aberle D; Brambilla C; Flieder D; Franklin W; Gazdar A; Gould M; Hasleton P; Henderson D; Johnson B; Johnson D; Kerr K; Kuriyama K; Lee JS; Miller VA; Petersen I; Roggli V; Rosell R; Saijo N; Thunnissen E; Tsao M; Yankelewitz D
J Thorac Oncol; 2011 Feb; 6(2):244-85. PubMed ID: 21252716
[TBL] [Abstract][Full Text] [Related]
3. Cancer cell immunity-related protein co-expression networks are associated with early-stage solid-predominant lung adenocarcinoma.
Nishimura T; Végvári Á; Nakamura H; Fujii K; Sakai H; Naruki S; Furuya N; Saji H
Front Oncol; 2024; 14():1273780. PubMed ID: 38450191
[TBL] [Abstract][Full Text] [Related]
4. Protein co-expression network-based profiles revealed from laser-microdissected cancerous cells of lung squamous-cell carcinomas.
Nishimura T; Fujii K; Nakamura H; Naruki S; Sakai H; Kimura H; Miyazawa T; Takagi M; Furuya N; Marko-Varga G; Kato H; Saji H
Sci Rep; 2021 Oct; 11(1):20209. PubMed ID: 34642392
[TBL] [Abstract][Full Text] [Related]
5. Pathologic subtype-defined prognosis is dependent on both tumor stage and status of oncogenic driver mutations in lung adenocarcinoma.
Dong Y; Li Y; Jin B; Zhang J; Shao J; Peng H; Tu S; Han B
Oncotarget; 2017 Oct; 8(47):82244-82255. PubMed ID: 29137260
[TBL] [Abstract][Full Text] [Related]
6. A proteomic profiling of laser-microdissected lung adenocarcinoma cells of early lepidic-types.
Kato Y; Nakamura H; Tojo H; Nomura M; Nagao T; Kawamura T; Kodama T; Ohira T; Ikeda N; Fehniger T; Marko-Varga G; Nishimura T; Kato H
Clin Transl Med; 2015 Dec; 4(1):64. PubMed ID: 26162278
[TBL] [Abstract][Full Text] [Related]
7. Targeted Sequencing Analysis of Predominant Histological Subtypes in Resected Stage I Invasive Lung Adenocarcinoma.
Li Y; Tan Y; Hu S; Xie J; Yan Z; Zhang X; Zong Y; Han-Zhang H; Li Q; Li C
J Cancer; 2021; 12(11):3222-3229. PubMed ID: 33976731
[No Abstract] [Full Text] [Related]
8. Aggressive tumor microenvironment of solid predominant lung adenocarcinoma subtype harboring with epidermal growth factor receptor mutations.
Saruwatari K; Ikemura S; Sekihara K; Kuwata T; Fujii S; Umemura S; Kirita K; Matsumoto S; Yoh K; Niho S; Ohmatsu H; Ochiai A; Kohrogi H; Tsuboi M; Goto K; Ishii G
Lung Cancer; 2016 Jan; 91():7-14. PubMed ID: 26711928
[TBL] [Abstract][Full Text] [Related]
9. Multi-omics analysis unravels the underlying mechanisms of poor prognosis and differential therapeutic responses of solid predominant lung adenocarcinoma.
Li F; Wang S; Wang Y; Lv Z; Jin D; Yi H; Fu L; Zhai S; Xiao T; Mao Y
Front Immunol; 2023; 14():1101649. PubMed ID: 36845145
[TBL] [Abstract][Full Text] [Related]
10. Proteogenomic analysis of lung adenocarcinoma reveals tumor heterogeneity, survival determinants, and therapeutically relevant pathways.
Soltis AR; Bateman NW; Liu J; Nguyen T; Franks TJ; Zhang X; Dalgard CL; Viollet C; Somiari S; Yan C; Zeman K; Skinner WJ; Lee JSH; Pollard HB; Turner C; Petricoin EF; Meerzaman D; Conrads TP; Hu H; ; Shriver CD; Moskaluk CA; Browning RF; Wilkerson MD
Cell Rep Med; 2022 Nov; 3(11):100819. PubMed ID: 36384096
[TBL] [Abstract][Full Text] [Related]
11. Comparison of clinical results between high grade patterns in stage I lung adenocarcinoma.
Jeon HW; Kim YD; Sim SB; Moon MH
Thorac Cancer; 2022 Sep; 13(17):2473-2479. PubMed ID: 35820717
[TBL] [Abstract][Full Text] [Related]
12. PANTHER: Making genome-scale phylogenetics accessible to all.
Thomas PD; Ebert D; Muruganujan A; Mushayahama T; Albou LP; Mi H
Protein Sci; 2022 Jan; 31(1):8-22. PubMed ID: 34717010
[TBL] [Abstract][Full Text] [Related]
13. Web-Based Survival Analysis Tool Tailored for Medical Research (KMplot): Development and Implementation.
Lánczky A; Győrffy B
J Med Internet Res; 2021 Jul; 23(7):e27633. PubMed ID: 34309564
[TBL] [Abstract][Full Text] [Related]
14. Mitochondrial Caseinolytic Protease P: A Possible Novel Prognostic Marker and Therapeutic Target in Cancer.
Cormio A; Sanguedolce F; Pesce V; Musicco C
Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34207660
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
